Return to Home Mortality > Table > Interpret

Interpretation of Death Rates Data

Death Rate Report by State

Esophagus, 2019-2023

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Death Rate (95% Confidence Interval) - The death rate is based upon 100,000 people and is for 5 year(s). Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population (the Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal).

Recent Trends - This is an interpretation of the AAPC:

AAPC (95% Confidence Interval) - The Average Annual Percent Change is the change in rate over time. These AAPCs are based upon APCs that were calculated by Joinpoint Regression Program


Other Notes


Line by Line Interpretation of the Report


Maine


West Virginia


Vermont


Indiana


Wyoming


Ohio


Nebraska


Michigan


Iowa


South Dakota


Missouri


Kentucky


New Hampshire


Pennsylvania


Wisconsin


Alaska


Oklahoma


Oregon


Montana


North Dakota


Kansas


Tennessee


Arkansas


Minnesota


Illinois


Massachusetts


Nevada


Washington


Mississippi


Idaho


South Carolina


Rhode Island


Louisiana


Virginia


New Mexico


Connecticut


North Carolina


Alabama


Arizona


Georgia


Delaware


Florida


Maryland


Texas


Colorado


New York


New Jersey


California


District of Columbia


Utah


Hawaii


Puerto Rico





Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 5:13 pm.

State Cancer Registries may provide more current or more local data.

† Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (20 age groups: <1, 1-4, 5-9, ... , 80-84, 85-89, 90+).

Population counts for denominators are based on Census populations as modified by NCI.

The US Population Data File is used with mortality data.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.